2023 Q3 Form 10-K Financial Statement

#000095017023043659 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023
Revenue $123.9M $130.3M $580.6M
YoY Change -13.7% -11.05% -0.25%
Cost Of Revenue $116.3M $119.7M $532.1M
YoY Change -11.41% -11.15% 0.71%
Gross Profit $7.649M $10.60M $48.52M
YoY Change -38.05% -9.87% -9.69%
Gross Profit Margin 6.17% 8.13% 8.36%
Selling, General & Admin $9.911M $8.876M $40.45M
YoY Change -4.88% 26.6% 10.68%
% of Gross Profit 129.57% 83.74% 83.35%
Research & Development $7.637M $7.061M $28.89M
YoY Change 11.88% 2.17% 31.9%
% of Gross Profit 99.84% 66.62% 59.54%
Depreciation & Amortization $5.338M $5.151M $19.16M
YoY Change 22.38% 19.76% 698.13%
% of Gross Profit 69.79% 48.6% 39.48%
Operating Expenses $17.55M $15.94M $69.34M
YoY Change 1.76% 14.47% 18.63%
Operating Profit -$9.899M -$5.338M -$20.82M
YoY Change 102.14% 146.9% 341.2%
Interest Expense $111.0K $67.00K -$494.0K
YoY Change -50.88% -126.27% -145.95%
% of Operating Profit
Other Income/Expense, Net $29.00K -$8.000K -$52.00K
YoY Change -226.09% -73.33% -347.62%
Pretax Income -$9.815M -$5.279M -$21.36M
YoY Change 90.99% 115.73% 270.74%
Income Tax $800.0K $50.61M $47.50M
% Of Pretax Income
Net Earnings -$10.57M -$55.89M -$68.87M
YoY Change 133.89% 1030.94% 1212.23%
Net Earnings / Revenue -8.53% -42.89% -11.86%
Basic Earnings Per Share -$0.19 -$1.28
Diluted Earnings Per Share -$0.19 -$1.03 -$1.28
COMMON SHARES
Basic Shares Outstanding 54.59M 54.12M 53.80M
Diluted Shares Outstanding 54.47M 53.80M

Balance Sheet

Concept 2023 Q3 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.31M $73.68M $73.68M
YoY Change -36.29% -23.6% -23.6%
Cash & Equivalents $56.31M $73.68M $73.68M
Short-Term Investments
Other Short-Term Assets $8.690M $9.779M $9.779M
YoY Change 66.73% 1535.28% 98.6%
Inventory
Prepaid Expenses $8.241M
Receivables $67.68M $67.75M $67.75M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $132.7M $151.2M $151.2M
YoY Change -21.53% -17.28% -17.28%
LONG-TERM ASSETS
Property, Plant & Equipment $19.50M $20.29M $20.29M
YoY Change 73.69% 117.86% 25.9%
Goodwill $121.1M $121.1M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.713M $5.825M $5.825M
YoY Change -6.14% -2.07% -88.39%
Total Long-Term Assets $188.3M $186.0M $186.0M
YoY Change -20.37% -21.58% -21.58%
TOTAL ASSETS
Total Short-Term Assets $132.7M $151.2M $151.2M
Total Long-Term Assets $188.3M $186.0M $186.0M
Total Assets $321.0M $337.2M $337.2M
YoY Change -20.85% -19.71% -19.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.29M $37.93M $37.93M
YoY Change -16.2% -10.57% -10.57%
Accrued Expenses $41.32M $44.01M $44.01M
YoY Change -19.06% -19.19% -19.19%
Deferred Revenue $0.00 $9.000K
YoY Change -100.0% -97.36%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.26M $89.82M $89.82M
YoY Change -20.23% -18.03% -18.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.33M $17.53M $17.53M
YoY Change -24.52% -14.35% -27.93%
Total Long-Term Liabilities $11.33M $17.53M $17.53M
YoY Change -24.52% -14.35% -27.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.26M $89.82M $89.82M
Total Long-Term Liabilities $11.33M $17.53M $17.53M
Total Liabilities $98.63M $107.4M $107.4M
YoY Change -19.34% -19.83% -19.83%
SHAREHOLDERS EQUITY
Retained Earnings -$109.6M -$99.08M
YoY Change 215.7% 227.93%
Common Stock $332.2M $329.1M
YoY Change 4.4% 4.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $222.3M $229.8M $229.8M
YoY Change
Total Liabilities & Shareholders Equity $321.0M $337.2M $337.2M
YoY Change -20.85% -19.71% -19.71%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023
OPERATING ACTIVITIES
Net Income -$10.57M -$55.89M -$68.87M
YoY Change 133.89% 1030.94% 1212.23%
Depreciation, Depletion And Amortization $5.338M $5.151M $19.16M
YoY Change 22.38% 19.76% 698.13%
Cash From Operating Activities -$4.973M $17.97M $11.84M
YoY Change -187.78% 133.64% -58.71%
INVESTING ACTIVITIES
Capital Expenditures $1.624M $4.470M $15.00M
YoY Change 241.18% -370.25% 427.94%
Acquisitions
YoY Change
Other Investing Activities -$1.000K -$121.0K
YoY Change -99.87% 40.7%
Cash From Investing Activities -$5.094M -$4.471M -$15.13M
YoY Change 67.73% 82.49% 63.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$2.427M
YoY Change -115.9%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.311M -2.782M -19.46M
YoY Change -31.55% -84.77% -41.59%
NET CHANGE
Cash From Operating Activities -4.973M 17.97M 11.84M
Cash From Investing Activities -5.094M -4.471M -15.13M
Cash From Financing Activities -7.311M -2.782M -19.46M
Net Change In Cash -17.37M 10.72M -22.75M
YoY Change 115.61% -182.29% 63.88%
FREE CASH FLOW
Cash From Operating Activities -$4.973M $17.97M $11.84M
Capital Expenditures $1.624M $4.470M $15.00M
Free Cash Flow -$6.597M $13.50M -$3.166M
YoY Change -227.13% 44.45% -112.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 qnst Fair Value Liabilities Level3 To Level1 Transfers Amount
FairValueLiabilitiesLevel3ToLevel1TransfersAmount
0
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q2 qnst Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 qnst Fair Value Of Assets Level2 To Level1 Transfers Amount
FairValueOfAssetsLevel2ToLevel1TransfersAmount
0
CY2023Q2 qnst Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2022Q2 qnst Fair Value Of Liabilities Level1 To Level2 Transfers Amount
FairValueOfLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q2 qnst Fair Value Of Assets Level1 To Level2 Transfers Amount
FairValueOfAssetsLevel1ToLevel2TransfersAmount
0
CY2022Q2 qnst Fair Value Of Liabilities Level2 To Level1 Transfers Amount
FairValueOfLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2022Q2 qnst Fair Value Liabilities Level3 To Level1 Transfers Amount
FairValueLiabilitiesLevel3ToLevel1TransfersAmount
0
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001117297
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2022Q2 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2021Q2 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q2 us-gaap Restricted Cash Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022 qnst Income Tax Reconciliation Expired Attributes
IncomeTaxReconciliationExpiredAttributes
261000
CY2022 qnst Income Tax Reconciliation Foreign Deferred Adjustment
IncomeTaxReconciliationForeignDeferredAdjustment
1354000
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-34628
CY2023 dei Entity Registrant Name
EntityRegistrantName
QuinStreet, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0512121
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
950 Tower Lane
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
6th Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Foster City
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94404
CY2023 dei City Area Code
CityAreaCode
650
CY2023 dei Local Phone Number
LocalPhoneNumber
587-7700
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023 dei Trading Symbol
TradingSymbol
QNST
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
735915628
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54586546
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
San Francisco, California
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73677000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96439000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3722000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1536000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67748000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81429000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9779000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4924000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
151204000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
182792000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16749000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9311000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3536000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6801000
CY2023Q2 us-gaap Goodwill
Goodwill
121141000
CY2022Q2 us-gaap Goodwill
Goodwill
121141000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38700000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
49696000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
44220000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5825000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5948000
CY2023Q2 us-gaap Assets
Assets
337155000
CY2022Q2 us-gaap Assets
Assets
419909000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
37926000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
42410000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44010000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54459000
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9000
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
341000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7875000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12369000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
89820000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
109579000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1261000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3858000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16273000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20472000
CY2023Q2 us-gaap Liabilities
Liabilities
107354000
CY2022Q2 us-gaap Liabilities
Liabilities
133909000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54192928
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54192928
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53356875
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53356875
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
54000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
53000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
329093000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
316422000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-266000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-261000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99080000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30214000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
229801000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
286000000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
337155000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
419909000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
580624000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
582099000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
578487000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
532101000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
528368000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
507956000
CY2023 us-gaap Gross Profit
GrossProfit
48523000
CY2022 us-gaap Gross Profit
GrossProfit
53731000
CY2021 us-gaap Gross Profit
GrossProfit
70531000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28893000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21906000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19344000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12542000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11042000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10991000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27904000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25501000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26270000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-20816000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-4718000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
13926000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
296000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
39000
CY2023 us-gaap Interest Expense
InterestExpense
790000
CY2022 us-gaap Interest Expense
InterestExpense
1075000
CY2021 us-gaap Interest Expense
InterestExpense
1296000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16660000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21362000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5762000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29329000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47504000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-514000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5774000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68866000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5248000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23555000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.28
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.28
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53799000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54339000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53166000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53799000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54339000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55129000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68866000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5248000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23555000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-18000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-18000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68871000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5254000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23537000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
255944000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3968000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19679000
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7980000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23555000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-18000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
295148000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1850000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18548000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7342000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
16950000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5248000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
286000000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
587000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2687000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18840000
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5389000
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4053000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68866000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
229801000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68866000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5248000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23555000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19155000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16961000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16201000
CY2023 qnst Provision For Recoveries From Sales Returns And Doubtful Accounts Receivable
ProvisionForRecoveriesFromSalesReturnsAndDoubtfulAccountsReceivable
2745000
CY2022 qnst Provision For Recoveries From Sales Returns And Doubtful Accounts Receivable
ProvisionForRecoveriesFromSalesReturnsAndDoubtfulAccountsReceivable
581000
CY2021 qnst Provision For Recoveries From Sales Returns And Doubtful Accounts Receivable
ProvisionForRecoveriesFromSalesReturnsAndDoubtfulAccountsReceivable
-341000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
18786000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
18506000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19633000
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-926000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2023 qnst Non Cash Lease Expense
NonCashLeaseExpense
-1081000
CY2022 qnst Non Cash Lease Expense
NonCashLeaseExpense
-1043000
CY2021 qnst Non Cash Lease Expense
NonCashLeaseExpense
-816000
CY2023 qnst Deferred Income Taxes
DeferredIncomeTaxes
47214000
CY2022 qnst Deferred Income Taxes
DeferredIncomeTaxes
-791000
CY2021 qnst Deferred Income Taxes
DeferredIncomeTaxes
5408000
CY2023 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0
CY2022 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
16615000
CY2023 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-149000
CY2022 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
482000
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
741000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10936000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5543000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20063000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4802000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3003000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5955000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-124000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
788000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
173000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4770000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2885000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6558000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7122000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5031000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10612000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-332000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
308000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-40000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11838000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28672000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
50615000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3062000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2842000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1969000
CY2023 qnst Payments To Acquire Businesses Net Of Net Assets Acquired
PaymentsToAcquireBusinessesNetOfNetAssetsAcquired
0
CY2022 qnst Payments To Acquire Businesses Net Of Net Assets Acquired
PaymentsToAcquireBusinessesNetOfNetAssetsAcquired
1797000
CY2021 qnst Payments To Acquire Businesses Net Of Net Assets Acquired
PaymentsToAcquireBusinessesNetOfNetAssetsAcquired
49304000
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
11942000
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4672000
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3131000
CY2023 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0
CY2022 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0
CY2021 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
21947000
CY2023 qnst Payments To Acquire Equity Investment
PaymentsToAcquireEquityInvestment
0
CY2022 qnst Payments To Acquire Equity Investment
PaymentsToAcquireEquityInvestment
0
CY2021 qnst Payments To Acquire Equity Investment
PaymentsToAcquireEquityInvestment
4000000
CY2023 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
121000
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-86000
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15125000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9225000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36457000
CY2023 qnst Proceeds From Stock Options Exercised And Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromStockOptionsExercisedAndIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
3219000
CY2022 qnst Proceeds From Stock Options Exercised And Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromStockOptionsExercisedAndIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
1854000
CY2021 qnst Proceeds From Stock Options Exercised And Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromStockOptionsExercisedAndIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
4357000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5389000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7342000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7980000
CY2023 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
11643000
CY2022 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
12559000
CY2021 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
7689000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5646000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15268000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19459000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33315000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11312000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-15000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-12000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-36000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22761000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13880000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2810000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
96453000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
110333000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107523000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
73692000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
96453000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
110333000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73677000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96439000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110318000
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
15000
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14000
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
15000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
73692000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
96453000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
110333000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
372000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
396000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
293000
CY2023 qnst Post Closing Payments For Acquisition Unpaid
PostClosingPaymentsForAcquisitionUnpaid
0
CY2022 qnst Post Closing Payments For Acquisition Unpaid
PostClosingPaymentsForAcquisitionUnpaid
2785000
CY2021 qnst Post Closing Payments For Acquisition Unpaid
PostClosingPaymentsForAcquisitionUnpaid
32192000
CY2023 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0
CY2022 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0
CY2021 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
2926000
CY2023 qnst Treasury Stock Retired Carrying Value
TreasuryStockRetiredCarryingValue
4053000
CY2022 qnst Treasury Stock Retired Carrying Value
TreasuryStockRetiredCarryingValue
16950000
CY2021 qnst Treasury Stock Retired Carrying Value
TreasuryStockRetiredCarryingValue
0
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1228000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
613000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
275000
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. The Company</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">QuinStreet, Inc. (the “Company”) is a leader in performance marketplaces and technologies for the financial services and home services industries. The Company was incorporated in California in April 1999 and reincorporated in Delaware in December 2009. The Company specializes in customer acquisition for clients in high value, information-intensive markets or “verticals,” including financial services, home services, and previously the historical education client vertical. The corporate headquarters are located in Foster City, California, with additional offices throughout the United States and India. The majority of the Company’s operations and revenue are in North America.</span></p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company’s investment portfolio consists of money market funds. Cash is deposited with financial institutions that management believes are creditworthy. To date, the Company has not experienced any material losses on its investment portfolio.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company maintains contracts with its clients, most of which are cancelable with little or no prior notice. In addition, these contracts do not contain penalty provisions for cancellation before the end of the contract term. The Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> client, The Progressive Corporation, that accounted for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of net revenue in fiscal years 2023, 2022 and 2021, and accounted for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of net accounts receivable as of June 30, 2022. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">One</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> additional client, The Allstate Corporation, accounted for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of net accounts receivable as of June 30, 2021. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> other client accounted for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% or more of net revenue in fiscal years 2023, 2022 and 2021, or </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% or more of net accounts receivable as of June 30, 2023 or 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023 qnst Maximum Period For Classifying As Cash And Cash Equivalents
MaximumPeriodForClassifyingAsCashAndCashEquivalents
P3M
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
120000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
120000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9287000
CY2023 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1972000
CY2022 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
0
CY2021 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
36000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
9087000
CY2023 qnst Recoveries Collected
RecoveriesCollected
0
CY2022 qnst Recoveries Collected
RecoveriesCollected
0
CY2021 qnst Recoveries Collected
RecoveriesCollected
-116000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2092000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
120000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
120000
CY2019Q1 qnst Allowance For Bad Debt
AllowanceForBadDebt
8700000
CY2023Q2 qnst Revenue Reserve
RevenueReserve
1600000
CY2022Q2 qnst Revenue Reserve
RevenueReserve
1400000
CY2023Q2 qnst Financing Receivable Allowance For Credit Losses Ans Revenue Reserve
FinancingReceivableAllowanceForCreditLossesAnsRevenueReserve
3700000
CY2022Q2 qnst Financing Receivable Allowance For Credit Losses Ans Revenue Reserve
FinancingReceivableAllowanceForCreditLossesAnsRevenueReserve
1500000
CY2023 qnst Minimum Useful Life Of Software For Capitalization Of Cost Incurred
MinimumUsefulLifeOfSoftwareForCapitalizationOfCostIncurred
P6M
CY2023 qnst Business Combination Period From Acquisition Date For Adjustments To Assets Acquired And Liabilities Assumed Maximum
BusinessCombinationPeriodFromAcquisitionDateForAdjustmentsToAssetsAcquiredAndLiabilitiesAssumedMaximum
P1Y
CY2022 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 qnst Fair Value Of Assets Level1 To Level2 Transfers Amount
FairValueOfAssetsLevel1ToLevel2TransfersAmount
0
CY2023Q2 qnst Fair Value Of Assets Level2 To Level1 Transfers Amount
FairValueOfAssetsLevel2ToLevel1TransfersAmount
0
CY2023Q2 qnst Fair Value Of Liabilities Level1 To Level2 Transfers Amount
FairValueOfLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2023Q2 qnst Fair Value Of Liabilities Level2 To Level1 Transfers Amount
FairValueOfLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2022Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y8M12D
CY2022Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
131000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
580624000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
582099000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
578487000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1418000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
598000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9779000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4924000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
341000
CY2023Q2 qnst Contract With Customer Prepaid Liability Current
ContractWithCustomerPrepaidLiabilityCurrent
1213000
CY2022Q2 qnst Contract With Customer Prepaid Liability Current
ContractWithCustomerPrepaidLiabilityCurrent
1163000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1222000
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1504000
CY2023Q2 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
8500000
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8800000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68866000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5248000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23555000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53799000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54339000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53166000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53799000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54339000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53166000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53799000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54339000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55129000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.28
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.28
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4247000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3557000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
84000
CY2021 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
20000000.0
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
71470000
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
82965000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3722000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1536000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67748000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81429000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8241000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4195000
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
120000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33352000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
76198000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16603000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
66887000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16749000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9311000
CY2023 us-gaap Depreciation
Depreciation
2800000
CY2022 us-gaap Depreciation
Depreciation
2400000
CY2021 us-gaap Depreciation
Depreciation
1800000
CY2023 qnst Amortization Of Internal Software Development Costs
AmortizationOfInternalSoftwareDevelopmentCosts
5300000
CY2022 qnst Amortization Of Internal Software Development Costs
AmortizationOfInternalSoftwareDevelopmentCosts
3000000.0
CY2021 qnst Amortization Of Internal Software Development Costs
AmortizationOfInternalSoftwareDevelopmentCosts
2600000
CY2023Q2 qnst Accrued Media Costs
AccruedMediaCosts
27302000
CY2022Q2 qnst Accrued Media Costs
AccruedMediaCosts
35552000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
8896000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
13513000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7812000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5394000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44010000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54459000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
195041000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
156341000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38700000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
194921000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
145225000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
49696000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11100000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11600000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11900000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-3000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
143000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
176000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
252000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
10208000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
8069000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5461000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4500000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
4037000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
6425000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38700000
CY2021Q2 us-gaap Goodwill
Goodwill
117833000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
3308000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q2 us-gaap Goodwill
Goodwill
121141000
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Goodwill
Goodwill
121141000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-21745000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6022000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
29433000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
383000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
260000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-104000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21362000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5762000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29329000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
224000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
195000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
187000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
367000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
371000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
436000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
40780000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1032000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
4732000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
6357000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
147000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
606000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
47137000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-885000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5338000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47504000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-514000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5774000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4486000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1210000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6180000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-752000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-314000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
206000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
61000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
11000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
59000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
676000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-774000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-2744000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
52396000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1034000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
671000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1847000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1174000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1131000
CY2023 qnst Income Tax Reconciliation Disqualified Compensation Expense
IncomeTaxReconciliationDisqualifiedCompensationExpense
744000
CY2022 qnst Income Tax Reconciliation Disqualified Compensation Expense
IncomeTaxReconciliationDisqualifiedCompensationExpense
1806000
CY2021 qnst Income Tax Reconciliation Disqualified Compensation Expense
IncomeTaxReconciliationDisqualifiedCompensationExpense
2219000
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
550000
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
385000
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
349000
CY2023 qnst Income Tax Reconciliation Expired Attributes
IncomeTaxReconciliationExpiredAttributes
273000
CY2021 qnst Income Tax Reconciliation Expired Attributes
IncomeTaxReconciliationExpiredAttributes
0
CY2023 qnst Income Tax Reconciliation Foreign Deferred Adjustment
IncomeTaxReconciliationForeignDeferredAdjustment
0
CY2021 qnst Income Tax Reconciliation Foreign Deferred Adjustment
IncomeTaxReconciliationForeignDeferredAdjustment
0
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-111000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
175000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-35000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47504000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-514000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5774000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1716000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1019000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3099000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3400000
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35430000
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
34684000
CY2023Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
246000
CY2022Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
217000
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
13790000
CY2022Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
11748000
CY2023Q2 qnst Deferred Tax Liabilities Operating Lease Liability Noncurrent
DeferredTaxLiabilitiesOperatingLeaseLiabilityNoncurrent
-960000
CY2022Q2 qnst Deferred Tax Liabilities Operating Lease Liability Noncurrent
DeferredTaxLiabilitiesOperatingLeaseLiabilityNoncurrent
-1894000
CY2023Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
7221000
CY2022Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
198000
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
39000
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
62660000
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
53001000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
59556000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7160000
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3104000
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
45841000
CY2023Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
5303000
CY2022Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2000
CY2023Q2 qnst Deferred Tax Liabilities Deferred Acquisition Costs Non Current
DeferredTaxLiabilitiesDeferredAcquisitionCostsNonCurrent
0
CY2022Q2 qnst Deferred Tax Liabilities Deferred Acquisition Costs Non Current
DeferredTaxLiabilitiesDeferredAcquisitionCostsNonCurrent
215000
CY2023Q2 qnst Deferred Tax Assets Operating Lease Right Of Use Assets Noncurrent
DeferredTaxAssetsOperatingLeaseRightOfUseAssetsNoncurrent
718000
CY2022Q2 qnst Deferred Tax Assets Operating Lease Right Of Use Assets Noncurrent
DeferredTaxAssetsOperatingLeaseRightOfUseAssetsNoncurrent
1404000
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6021000
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1621000
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2917000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
44220000
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2900000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
44200000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
59600000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7200000
CY2023 qnst Non Cash Charge To Income Tax Expense
NonCashChargeToIncomeTaxExpense
52400000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5296000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4756000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4236000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
717000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
542000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
535000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
19000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
7000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
8000
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6030000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5296000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4756000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
1500000
CY2023Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1100000
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
4790000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
5172000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
5247000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
638000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
619000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
785000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
666000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
676000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
571000
CY2023 us-gaap Lease Cost
LeaseCost
6094000
CY2022 us-gaap Lease Cost
LeaseCost
6467000
CY2021 us-gaap Lease Cost
LeaseCost
6603000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
5860000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
6206000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
6066000
CY2023 qnst Increase In Operating Lease Liability In Exchange For Right Of Use Asset Obtained
IncreaseInOperatingLeaseLiabilityInExchangeForRightOfUseAssetObtained
824000
CY2022 qnst Increase In Operating Lease Liability In Exchange For Right Of Use Asset Obtained
IncreaseInOperatingLeaseLiabilityInExchangeForRightOfUseAssetObtained
564000
CY2021 qnst Increase In Operating Lease Liability In Exchange For Right Of Use Asset Obtained
IncreaseInOperatingLeaseLiabilityInExchangeForRightOfUseAssetObtained
6981000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3956000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1089000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
339000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
128000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
34000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5546000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
968000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4578000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3317000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1261000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4578000
CY2023Q2 qnst Additional Operating Leases Undiscounted Future Minimum Payments Amount
AdditionalOperatingLeasesUndiscountedFutureMinimumPaymentsAmount
12800000
CY2022Q2 qnst Liabilities Related To Indemnification Agreement
LiabilitiesRelatedToIndemnificationAgreement
0
CY2023Q2 qnst Liabilities Related To Indemnification Agreement
LiabilitiesRelatedToIndemnificationAgreement
0
CY2022Q2 qnst Accrual For Indemnification Provisions
AccrualForIndemnificationProvisions
0
CY2023Q2 qnst Accrual For Indemnification Provisions
AccrualForIndemnificationProvisions
0
CY2023Q2 qnst Letters Of Credit For Fidelity Bonds
LettersOfCreditForFidelityBonds
500000
CY2023 qnst Period Of Cancellation Of Letter Of Credit From Annual Expiration Date
PeriodOfCancellationOfLetterOfCreditFromAnnualExpirationDate
P30D
CY2023 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
403193
CY2023 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
4100000
CY2023 qnst Stock Repurchased But Unsettled During Period Shares
StockRepurchasedButUnsettledDuringPeriodShares
10000
CY2023 qnst Stock Repurchased But Unsettled During Period Value
StockRepurchasedButUnsettledDuringPeriodValue
100000
CY2022 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
1652043
CY2022 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
16900000
CY2022 qnst Stock Repurchased But Unsettled During Period Shares
StockRepurchasedButUnsettledDuringPeriodShares
170197
CY2022 qnst Stock Repurchased But Unsettled During Period Value
StockRepurchasedButUnsettledDuringPeriodValue
1700000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
18800000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
18500000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19600000
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
800000
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2600000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
918093
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.10
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M20D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11578000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58420
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
17.38
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
412941
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.48
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9134
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.36
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6819
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
13.78
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
547619
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.33
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y9M3D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2110000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11306
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.18
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
109359
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.37
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2439
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.76
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3077
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.49
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
444050
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.10
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M10D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1283000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
440330
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.02
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y3M3D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1283000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
381218
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.68
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y10M17D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1283000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
693000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4262000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9408000
CY2023 qnst Employee Service Share Based Compensation Cash From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashFromExerciseOfStockOptions
587000
CY2022 qnst Employee Service Share Based Compensation Cash From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashFromExerciseOfStockOptions
1850000
CY2021 qnst Employee Service Share Based Compensation Cash From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashFromExerciseOfStockOptions
4279000
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
0
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
725000
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
1569000
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
500000
CY2023 qnst Director And Employee Service Share Based Compensation Nonvested Awards Unvested Stock Options Compensation Cost Not Yet Recognized Period For Recognition
DirectorAndEmployeeServiceShareBasedCompensationNonvestedAwardsUnvestedStockOptionsCompensationCostNotYetRecognizedPeriodForRecognition
P1Y9M18D
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
580624000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
582099000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
578487000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16749000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9311000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38700000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
49696000
CY2023 dei Auditor Firm
AuditorFirmId
238

Files In Submission

Name View Source Status
0000950170-23-043659-index-headers.html Edgar Link pending
0000950170-23-043659-index.html Edgar Link pending
0000950170-23-043659.txt Edgar Link pending
0000950170-23-043659-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img127107089_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
qnst-20230630.htm Edgar Link pending
qnst-20230630.xsd Edgar Link pending
qnst-ex21_1.htm Edgar Link pending
qnst-ex23_1.htm Edgar Link pending
qnst-ex31_1.htm Edgar Link pending
qnst-ex31_2.htm Edgar Link pending
qnst-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qnst-20230630_def.xml Edgar Link unprocessable
qnst-20230630_cal.xml Edgar Link unprocessable
qnst-20230630_lab.xml Edgar Link unprocessable
qnst-20230630_pre.xml Edgar Link unprocessable
qnst-20230630_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending